📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. (2015)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciu1167

PubMed Identifier: 25567330

Publication URI: http://europepmc.org/abstract/MED/25567330

Type: Journal Article/Review

Volume: 60

Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Issue: 8

ISSN: 1058-4838